Interactions of HPV E6 and E7 oncoproteins with tumour suppressor gene products.
about
Differential specificity for binding of retinoblastoma binding protein 2 to RB, p107, and TATA-binding proteinThe causal relation between human papillomavirus and cervical cancer.Hepatitis B virus X protein interacts with a probable cellular DNA repair proteinMolecular concept in human oral cancerLamina-associated polypeptide (LAP)2α and other LEM proteins in cancer biologyImmune enhancement of skin carcinogenesis by CD4+ T cells.Abrogation of the Brd4-positive transcription elongation factor B complex by papillomavirus E2 protein contributes to viral oncogene repressionThe distribution and common amino acid polymorphisms of human papillomavirus (HPV)-31 variants in 2700 women from Northern ChinaPapillomavirus interaction with cellular chromatin.Synergistic cytotoxic effects of a combined treatment of a Pinellia pedatisecta lipid-soluble extract and cisplatin on human cervical carcinoma in vivo.Human papillomavirus oncoproteins E6 and E7 independently abrogate the mitotic spindle checkpoint.Enumeration of the simian virus 40 early region elements necessary for human cell transformationHigh-risk human papillomavirus E6 protein promotes reprogramming of Fanconi anemia patient cells through repression of p53 but does not allow for sustained growth of induced pluripotent stem cells.Human papillomavirus type 16 E2 protein has no effect on transcription from episomal viral DNA.New molecular targets against cervical cancer.Inhibition of human papilloma virus E2 DNA binding protein by covalently linked polyamides.MK3 modulation affects BMI1-dependent and independent cell cycle check-points.Neuroepithelial carcinomas in mice transgenic with human papillomavirus type 16 E6/E7 ORFsChemoradiotherapy-induced upregulation of PD-1 antagonizes immunity to HPV-related oropharyngeal cancer.Papilloma formation in human foreskin xenografts after inoculation of human papillomavirus type 16 DNA.Translation of the human papillomavirus type 16 E7 oncoprotein from bicistronic mRNA is independent of splicing events within the E6 open reading frame.Human papillomavirus type 16 variant lineages in United States populations characterized by nucleotide sequence analysis of the E6, L2, and L1 coding segments.Analysis of the p53-mediated G1 growth arrest pathway in cells expressing the human papillomavirus type 16 E7 oncoproteinDirect identification of an HPV-16 tumor antigen from cervical cancer biopsy specimensCudrania tricuspidata Stem Extract Induces Apoptosis via the Extrinsic Pathway in SiHa Cervical Cancer Cells.An oncogenic form of p53 confers a dominant, gain-of-function phenotype that disrupts spindle checkpoint control.DNA tumor virus oncoproteins and retinoblastoma gene mutations share the ability to relieve the cell's requirement for cyclin D1 function in G1The invisible enemy - how human papillomaviruses avoid recognition and clearance by the host immune system.Progressive squamous epithelial neoplasia in K14-human papillomavirus type 16 transgenic miceReversible repression of papillomavirus oncogene expression in cervical carcinoma cells: consequences for the phenotype and E6-p53 and E7-pRB interactionsHuman cancer cell lines express a negative transcriptional regulator of the interferon regulatory factor family of DNA binding proteins.Update on molecular diagnostic tests in head and neck cancerHPV-based Tests for Cervical Cancer Screening and Management of Cervical Disease.The interaction between human papillomavirus type 16 and FADD is mediated by a novel E6 binding domain.Answering human papillomavirus vaccine concerns; a matter of science and time.Guidelines of the Italian Society for Virology on HPV testing and vaccination for cervical cancer prevention.Genetic heterogeneity of oncogenic human papillomavirus type 5 (HPV5) and phylogeny of HPV5 variants associated with epidermodysplasia verruciformis.BC-box protein domain-related mechanism for VHL protein degradation.Adeno-associated virus type 2 induces apoptosis in human papillomavirus-infected cell lines but not in normal keratinocytes.Role of SKP1-CUL1-F-box-protein (SCF) E3 ubiquitin ligases in skin cancer.
P2860
Q24608934-3C65CD95-1B0B-4C05-A7A8-676D73FAB0DEQ24673148-8065D023-28A9-4603-B970-AE9FBD7282E7Q24676695-8BE5C1B9-E54D-4466-A082-558BC802803FQ26775850-C6F35B34-8A58-4A0C-AF9D-59B38DEA4395Q27687804-A5AD312F-DE6F-49DE-AE05-6E874D883BFBQ33186709-06463E0E-1C3E-4668-9B25-FC58578AA7FFQ33558774-8B0FF76E-F8AC-4423-8E1F-8539251A12B0Q33717274-FE399F57-6E1A-4889-B5EA-B5173E672350Q33729502-5835E682-0C9D-4098-8E6F-3774F51BDF86Q33750771-6B9B1939-CE3D-4AAA-9017-0FF8D6D09B2AQ34069364-0FFDB95C-59BB-40FC-A42C-89ACBDB85F1FQ34117528-4562AF69-23A0-4504-AA9B-8B68A53A6B11Q34261778-B9C25FF8-13B5-4916-B0B9-ACDF5A8CAEDDQ34467609-9D483539-7AC3-45AB-9F8B-12674BA0CFC5Q34700859-C91AC08F-C83B-4CE1-B3D7-920EAF6CA598Q34770731-3FD1BB46-2741-4F48-82B0-ED4F65087F1DQ35597530-AC0234CF-917C-468F-8072-EB8D3B7DD2B5Q35832738-41448A83-7F65-4BA2-854F-20B30419942FQ35837683-D6CC7FBB-BE11-4DFD-8BC2-C4F651527849Q35838448-0B48B172-D4C9-4841-9DE3-B28482CEBF67Q35850926-AE5FDD25-1CAF-44F9-B25B-3FF8C2CA936BQ35852125-9E518E2D-ED1A-47CE-B92B-C820BCD74390Q35880696-62B4EC68-068E-4EAE-A70B-2F4B844F6209Q35928124-D8C85309-5116-4668-86F9-4964F26F3C03Q35951428-6CE642A7-63C6-497A-BC6D-83A1ED7A3E27Q36065506-DA90B3F9-5BEB-4B49-8D2D-4E95274856DAQ36234063-AB890D96-0454-4F89-A763-440C236ECCE9Q36541450-0143411E-F252-4479-818B-60E09983AB1EQ36622112-57DD967E-819D-4EE0-A246-6DF494606DD8Q36633110-A053FBF8-8A0B-47FF-806B-110812018B90Q36647166-2676D713-1A09-4A97-9D11-6D9201FC98B3Q36798480-9EF23028-418F-40BF-8A77-BB7B7834DCB0Q36856284-91D5CBF1-6391-439E-AF23-7F04606120A2Q36898915-807FF276-8756-4ADB-9823-3B071B8FF920Q36952972-CCE26702-0A34-4602-B3A4-010E8C0D5A17Q37066141-BD970965-D9CA-479B-9492-13766567D002Q37141662-4E4B9878-DF7D-468E-9B79-435C3A4FD583Q37318235-578BD683-FE85-4984-9B78-738937F05A6DQ37356092-29EC07CA-D05B-45DC-889F-3F1845F0175BQ37388126-66E9B5F1-2A4E-4877-8EBF-532858C41C97
P2860
Interactions of HPV E6 and E7 oncoproteins with tumour suppressor gene products.
description
1992 nî lūn-bûn
@nan
1992 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
Interactions of HPV E6 and E7 oncoproteins with tumour suppressor gene products.
@ast
Interactions of HPV E6 and E7 oncoproteins with tumour suppressor gene products.
@en
type
label
Interactions of HPV E6 and E7 oncoproteins with tumour suppressor gene products.
@ast
Interactions of HPV E6 and E7 oncoproteins with tumour suppressor gene products.
@en
prefLabel
Interactions of HPV E6 and E7 oncoproteins with tumour suppressor gene products.
@ast
Interactions of HPV E6 and E7 oncoproteins with tumour suppressor gene products.
@en
P2093
P1433
P1476
Interactions of HPV E6 and E7 oncoproteins with tumour suppressor gene products.
@en
P2093
Huibregtse JM
Scheffner M
P304
P577
1992-01-01T00:00:00Z